follow me on the BLUE SKY BREAKOUT board
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
FNMA~~~ $1.92 >>>>>>
Good morning SHMN investors
That is great!
True SHMN posted net profit
have a great weekend!
have a great weekend
It is very good, Friday, probably next week pink current and boom to multi-pennies
Agree balamidas:)
Great article about Jane Street! https://www.ft.com/content/81811f27-4a8f-4941-99b3-2762cae76542
I think so.. yesterday there was some great updates
Added some
I guess so
Very thin ... .01++ level
I believe next week pink current >>>
SHMN .01++ coming here we gooo >>>
Good morning NSAV board
Good morning SHMN investors
SHMN tier changed to Pink Limited. https://www.otcmarkets.com/stock/SHMN/disclosure
SHMN tier changed to Pink Limited. https://www.otcmarkets.com/stock/SHMN/disclosure
you can say that again!
SHMN great day closed GREEN ~~
NSAV great updates closed 24.4% up >>>>>
SHMN ~NEWS~ SOHM, Inc., Receives a Mandate for Development, Manufacturing, and Supply skincare topical products.
03/25/2021 posted in Press Releases
Share
CHINO HILLS, CA—March 25, 2021 – SOHM, Inc. (Pink Sheets: SHMN), a generic Pharmaceutical, Nutraceutical, and Cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announced today that the company has received a mandate for development, manufacturing and supply seven new skincare SKU for its human prescription topical products.
Today, Mr. Baron Night, CEO announce that SOHM has received a mandate from one of its customers for the development, manufacturing, and supply of seven of the customer’s new products. These products are human prescription products and are in use in skin care and acne care. These mandates will be strengthening the company’s efforts to continue its B2B business under a private label agreement.
This mandate and scope of the project is just the beginning of launching its products into major pharmacy retail stores. SOHM’s customer will be distributing them to various pharmacy chain stores that include Publix, CVS and Wal-Mart throughout the United States.
Upon execution of these mandates in the coming months, the company will have 14 different compositions and SKU’s and different categories of products which include Gel, Cleanser, Cream, suspension, etc. The company targets to develop every month at least two products and finish the development and supply in the next 4 to 5 months.
Mr. Baron Night, CEO said, “SOHM is very pleased to have received this new mandate and project. Upon completion of these mandates, the company’s revenue stream will be having very positive growth in 2021 and the coming years. This represents an annualized commitment once this order is executed and the product is on the shelf of pharmacies distribution and pharmacy retail stores”.
The management continue and assures that SOHM achieves its target for higher revenue growth in 2021 compared to previous years.
About SOHM, Inc.
SOHM, Inc., is a growing generic pharmaceutical manufacturing and marketing company with a vision “Globalè Prospèro” that tries to build continuous growth. SOHM manufacturing and marketing targets the rapidly growing healthcare segments such as Nutraceuticals, Cosmeceuticals, and other major therapeutic segments. SOHM is headquartered in North America with manufacturing alliances in India as well as has strategic alliances with US manufacturing facilities. Although SOHM’s generic pharmaceuticals are exported globally and were introduced to the USA in early 2013, SOHM continues its focus on distribution to emerging markets in Africa, Latin America, and Southeast Asia.
To know more about SOHM, Inc., visit www.SOHM.com
Safe Harbor Statement:
This news release contains “forward-looking statements”, which are statements that are not purely historical and include any statements regarding beliefs, plans, expectations, or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs, and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations, and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations, or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report for the most recent fiscal year, our quarterly reports uploaded from time-to-time on OTCMarkets.com.
For more information, please contact:
SOHM, Inc.
714-522-6700
https://www.sohm.com/2021/03/25/sohm-inc-receives-a-mandate-for-development-manufacturing-and-supply-skincare-topical-products/#.YFzCphffBsM.twitter
The management continue and assures that SOHM achieves its target for higher revenue growth in 2021 compared to previous years.
SHMN ~News: Distributing products to Publix, CVS and Wal-Mart throughout the United States.
SOHM, Inc., Receives a Mandate for Development, Manufacturing, and Supply skincare topical products.
03/25/2021 posted in Press Releases
Share
CHINO HILLS, CA—March 25, 2021 – SOHM, Inc. (Pink Sheets: SHMN), a generic Pharmaceutical, Nutraceutical, and Cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announced today that the company has received a mandate for development, manufacturing and supply seven new skincare SKU for its human prescription topical products.
Today, Mr. Baron Night, CEO announce that SOHM has received a mandate from one of its customers for the development, manufacturing, and supply of seven of the customer’s new products. These products are human prescription products and are in use in skin care and acne care. These mandates will be strengthening the company’s efforts to continue its B2B business under a private label agreement.
This mandate and scope of the project is just the beginning of launching its products into major pharmacy retail stores. SOHM’s customer will be distributing them to various pharmacy chain stores that include Publix, CVS and Wal-Mart throughout the United States.
Upon execution of these mandates in the coming months, the company will have 14 different compositions and SKU’s and different categories of products which include Gel, Cleanser, Cream, suspension, etc. The company targets to develop every month at least two products and finish the development and supply in the next 4 to 5 months.
Mr. Baron Night, CEO said, “SOHM is very pleased to have received this new mandate and project. Upon completion of these mandates, the company’s revenue stream will be having very positive growth in 2021 and the coming years. This represents an annualized commitment once this order is executed and the product is on the shelf of pharmacies distribution and pharmacy retail stores”.
The management continue and assures that SOHM achieves its target for higher revenue growth in 2021 compared to previous years.
About SOHM, Inc.
SOHM, Inc., is a growing generic pharmaceutical manufacturing and marketing company with a vision “Globalè Prospèro” that tries to build continuous growth. SOHM manufacturing and marketing targets the rapidly growing healthcare segments such as Nutraceuticals, Cosmeceuticals, and other major therapeutic segments. SOHM is headquartered in North America with manufacturing alliances in India as well as has strategic alliances with US manufacturing facilities. Although SOHM’s generic pharmaceuticals are exported globally and were introduced to the USA in early 2013, SOHM continues its focus on distribution to emerging markets in Africa, Latin America, and Southeast Asia.
To know more about SOHM, Inc., visit www.SOHM.com
Safe Harbor Statement:
This news release contains “forward-looking statements”, which are statements that are not purely historical and include any statements regarding beliefs, plans, expectations, or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs, and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations, and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations, or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report for the most recent fiscal year, our quarterly reports uploaded from time-to-time on OTCMarkets.com.
For more information, please contact:
SOHM, Inc.
714-522-6700
https://www.sohm.com/2021/03/25/sohm-inc-receives-a-mandate-for-development-manufacturing-and-supply-skincare-topical-products/#.YFzCphffBsM.twitter
SHMN huge news:~Publix, CVS and Wal-Mart
SOHM, Inc., Receives a Mandate for Development, Manufacturing, and Supply skincare topical products.
03/25/2021 posted in Press Releases
Share
CHINO HILLS, CA—March 25, 2021 – SOHM, Inc. (Pink Sheets: SHMN), a generic Pharmaceutical, Nutraceutical, and Cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announced today that the company has received a mandate for development, manufacturing and supply seven new skincare SKU for its human prescription topical products.
Today, Mr. Baron Night, CEO announce that SOHM has received a mandate from one of its customers for the development, manufacturing, and supply of seven of the customer’s new products. These products are human prescription products and are in use in skin care and acne care. These mandates will be strengthening the company’s efforts to continue its B2B business under a private label agreement.
This mandate and scope of the project is just the beginning of launching its products into major pharmacy retail stores. SOHM’s customer will be distributing them to various pharmacy chain stores that include Publix, CVS and Wal-Mart throughout the United States.
Upon execution of these mandates in the coming months, the company will have 14 different compositions and SKU’s and different categories of products which include Gel, Cleanser, Cream, suspension, etc. The company targets to develop every month at least two products and finish the development and supply in the next 4 to 5 months.
Mr. Baron Night, CEO said, “SOHM is very pleased to have received this new mandate and project. Upon completion of these mandates, the company’s revenue stream will be having very positive growth in 2021 and the coming years. This represents an annualized commitment once this order is executed and the product is on the shelf of pharmacies distribution and pharmacy retail stores”.
The management continue and assures that SOHM achieves its target for higher revenue growth in 2021 compared to previous years.
About SOHM, Inc.
SOHM, Inc., is a growing generic pharmaceutical manufacturing and marketing company with a vision “Globalè Prospèro” that tries to build continuous growth. SOHM manufacturing and marketing targets the rapidly growing healthcare segments such as Nutraceuticals, Cosmeceuticals, and other major therapeutic segments. SOHM is headquartered in North America with manufacturing alliances in India as well as has strategic alliances with US manufacturing facilities. Although SOHM’s generic pharmaceuticals are exported globally and were introduced to the USA in early 2013, SOHM continues its focus on distribution to emerging markets in Africa, Latin America, and Southeast Asia.
To know more about SOHM, Inc., visit www.SOHM.com
Safe Harbor Statement:
This news release contains “forward-looking statements”, which are statements that are not purely historical and include any statements regarding beliefs, plans, expectations, or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs, and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations, and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations, or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report for the most recent fiscal year, our quarterly reports uploaded from time-to-time on OTCMarkets.com.
For more information, please contact:
SOHM, Inc.
714-522-6700
https://www.sohm.com/2021/03/25/sohm-inc-receives-a-mandate-for-development-manufacturing-and-supply-skincare-topical-products/#.YFzCphffBsM.twitter
SHMN~We are happy with our ongoing efforts and actions on strengthening our revenues and operation
https://twitter.com/sohminc
lol:)
WCEXF revenue increased to $2,649,140 from $75,562
World Class Extractions Reports Operating and Financial Results for the Nine-Month Period Ended January 31, 2021
Thu March 25, 2021 3:30 AM|Accesswire|About: WCEXF
World-Class continues to show substantial revenue growth quarter-over-quarter with revenue of $2,649,140 for the quarter ended January 31, 2021 compared to revenue of $75,562 for the quarter ended January 31, 2020
VANCOUVER, BC / ACCESSWIRE / March 25, 2021 / World-Class Extractions Inc. (CSE:PUMP)(FRA:WCF)(OTCQB:WCEXF) (the "Company" or "World-Class"), is pleased to report the operating and financial results for its third quarter ended January 31, 2021.
Financial (unaudited)
Revenue of $2,649,140 for the quarter ended January 31, 2021 compared to $2,289,799 for the quarter ended October 31, 2020 and $75,562 revenue for the quarter ended January 31, 2020 - a 2,653% revenue growth from January 2020 to January 2021. The increase in revenue is primarily attributable to the operations of PED.
Gross margin for the quarter ended January 31, 2021 was 27%, consistent with the gross margin figure for the month of January 2021 reported in the Company's news release dated March 2, 2021, but down slightly from the gross margin figures reported for the individual months of November and December 2020.
The Company had cash at January 31, 2021 of $3,017,799 (April 30, 2020 - $5,632,160).
Working capital as at January 31, 2021 is $911,231.
The Company has long-term debt consisting of $819,216 in non-current portion of lease obligations and $92,061 in non-current loans payable.
The net loss and comprehensive loss for the three months ended January 31, 2021 was $626,878 (as compared to January 31, 2020 of $33,144,218). The loss for the three-month quarter ended January 31, 2021 (with comparisons for the quarter ended January 31, 2020) is mainly attributed to the following:
depreciation and amortization expense of $157,600 (2020 - $775,844), consulting fees of $8,500 (2020 - $132,102),; filing fees of $25,592 (2020 - $26,075); development and research expenses of $97,600 (2020 - $830,180); lease interest of $66,151 (2020 - $42,348); office expense of $140,684 (2020 - $156,933); professional fees of $166,328 (2020 - $195,315); management fees of $55,500 (2020 - $57,675), remuneration and benefits of $544,140 (2020 - $640,550); share-based payments of $11,865 (2020 - $241,131) and impairment loss of $Nil (2020 - 29,364,656)
Company Summary and Highlights
Pineapple Express Delivery Inc.
World-Class holds a controlling interest in Pineapple Express Delivery Inc. ("PED"), a company which offers compliant and secure delivery of government regulated products, including medical and recreational cannabis in Ontario, Manitoba and Saskatchewan, and liquor delivery in certain jurisdictions in Saskatchewan.
Since the Company's acquisition of a controlling interest in PED, PED has achieved the following milestones:
A total of 580,732 cannabis and alcohol deliveries for the nine months ended January 31, 2021 were made. The fluctuations in deliveries quarter over quarter are due to the COVID-19 lockdown measures put in place in the Greater Toronto Area with volumes increasing during these lockdowns. Total deliveries per quarters: 209,676 - three months ended January 31, 2021, 181,569 - three months ended October 31, 2020 and 189,487 - three months ended July 31, 2020.
The number of drivers changed from 55 at the beginning of 2020, to approximately 190 by the end of July 31, 2020, 180 by October 31, 2020 and 200 by January 31, 2021. Efficiencies have also been created by routing deliveries through hub expansions and concentrating drivers to tighter geographical areas, leading to less hours used by drivers for the timely delivery of packages.
Offering same day cannabis delivery service in 37 cities (183 postal code regions) and 3-day service in 65 cities (288 postal code regions) in Ontario, PED expanded cannabis delivery services to Ottawa, Barrie, Kingston, London, and the Windsor/Chatham region.
Expanded liquor delivery services to provide same-day and next-day delivery of wine, spirits and beer products from Saskatoon Co-op's Wine-Spirits-Beer retail stores in Saskatoon, Warman and Martensville.
Partnered with Medical Cannabis by Shoppers™ to offer same-day delivery to their medical cannabis patients in cities in and around the Greater Toronto Area (GTA).
Partnered with Spectrum Therapeutics, the medical division of Canopy Growth Corporation to bring same-day delivery to medical cannabis patients in the GTA.
Partnered with CannTrust Inc. to provide deliveries for estoraTM medical cannabis products to CannTrust patients in Ontario, under the name "Trust Delivery - Powered by Pineapple Express".
Several contracts in place with Health Canada license holders for delivery within select provinces in Canada (B2B cannabis delivery services).
Late-stage applicant to Health Canada to obtain a ‘Sale for Medical Purposes' license for its facility located in the GTA. With a population of 6-million people, this sales license gives PED the ability to store inventory for other license holders, allowing PED to leverage its facility in the GTA and offer same day delivery services to the patients of those LPs.
The Company cautions that figures for revenue, gross margin, and number of deliveries generated from the services offered by Pineapple Express Delivery have not been audited beyond April 30, 2020 and any monthly updates are based on calculations prepared by the Company and management of Pineapple Express Delivery. Actual results may differ from those reported in this release once figures have been audited.
Soma Labs
The Company's subsidiary, Soma Labs Scientific Inc. ("Soma"), has focused on production, quality and compliance of systems, technologies, processes and procedures for cannabis and hemp extraction and processing, including the BOSS CO2 Extraction System and the BEAST Ethanol Extraction System. World-Class continues to focus on monetizing its Soma Labs' assets, including the extraction and processing systems, technology and processes to produce cannabis and hemp concentrates and end-products.
Patent Applications and Information
The Company has previously filed, and will continue to file, patent applications directed to its proprietary systems and methods for producing cannabis and hemp extracts. Such systems and methods are believed to be novel and non-obvious, based on the ability of the World-Class Technologies to produce extracts that have substantially greater concentrations of target cannabinoids and possess minimal contaminants. Additional advantages of the World-Class Technologies include the ability to process very large volumes of cannabis and hemp plant material.
The United States Patent and Trademark Office ("USPTO") has awarded the Company the following U.S. Patents:
U.S. Patent No. 10,851,077, issued on December 1, 2020 in relation to the Company's methods for extracting and concentrating cannabinoids and other target compounds from cannabis using ultrasound-enhanced solvent extraction. WCE's patented plant processing technology allows for prompt cannabinoid extraction following harvest, including the root and all other parts of the hemp plant and further utilizes ethanol for extraction, as opposed to the use of toxic hydrocarbon solvents. WCE's patented process additionally uses precisely focused ultrasound to release cannabinoids from the hemp plant that produces CBD yields that are believed to be among the highest in the industry while also minimizing biomass waste and solvent usage.
U.S. Patent No. 10,946,306, issued on March 16, 2021 in relation to the Company's methods for the systematic extraction and concentration of cannabinoids and other target compounds via solvent extraction from large scale harvests of cannabis and hemp crops. World-Class' patent process minimizes energy consumption, conserves the volume of solvent utilized in the extraction process, and maximizes the quantity of cannabinoids sought to be extracted on a large-scale, commercial basis, than other known cannabinoid extraction techniques.
These patents continue to supplement World-Class' goal to achieve the most sustainable, efficient, and economical method of large-scale commercial production of cannabis plant material.
Update regarding Cobra Ventures & HydRx Farms Debenture Investment
During the period ended January 31, 2021, World-Class provided a $2.5M loan to Cobra Ventures Inc. ("Cobra") with respect to a debenture purchase of HydRx Farms Ltd. operating as Scientus Pharma("HydRx"). World-Class subsequently sold its 50% interest in Cobra to the remaining shareholder of Cobra, the sale of which included the receipt of all funds ($2.5 million) previously advanced by World-Class to Cobra. The World-Class loan was paid out in full, and World-Class has no further interest in Cobra and no ongoing role or involvement with HydRx or the HydRx debenture.
About World-Class Extractions Inc.
World-Class is an innovation-driven company with a principle focus on the rapidly evolving cannabis and hemp industries. World-Class offers compliant and secure delivery of government regulated products through its subsidiary Pineapple Express Delivery Inc., including medical and recreational cannabis in Ontario, Manitoba and Saskatchewan, and liquor delivery in certain jurisdictions in Saskatchewan. World-Class continues to investigate opportunities to deploy and manage custom-built extraction centres utilizing its custom systems, technology, and processes to efficiently produce high-quality cannabis and hemp concentrates and end-products.
Contact
World-Class Investor Relations
1-437-266-1968
ir@worldclassextractions.com
https://worldclassextractions.com
https://seekingalpha.com/pr/18245831-world-class-extractions-reports-operating-and-financial-results-for-nine-month-period-ended
WCEXF revenue increased to $2,649,140 from $75,562
World Class Extractions Reports Operating and Financial Results for the Nine-Month Period Ended January 31, 2021
Thu March 25, 2021 3:30 AM|Accesswire|About: WCEXF
World-Class continues to show substantial revenue growth quarter-over-quarter with revenue of $2,649,140 for the quarter ended January 31, 2021 compared to revenue of $75,562 for the quarter ended January 31, 2020
VANCOUVER, BC / ACCESSWIRE / March 25, 2021 / World-Class Extractions Inc. (CSE:PUMP)(FRA:WCF)(OTCQB:WCEXF) (the "Company" or "World-Class"), is pleased to report the operating and financial results for its third quarter ended January 31, 2021.
Financial (unaudited)
Revenue of $2,649,140 for the quarter ended January 31, 2021 compared to $2,289,799 for the quarter ended October 31, 2020 and $75,562 revenue for the quarter ended January 31, 2020 - a 2,653% revenue growth from January 2020 to January 2021. The increase in revenue is primarily attributable to the operations of PED.
Gross margin for the quarter ended January 31, 2021 was 27%, consistent with the gross margin figure for the month of January 2021 reported in the Company's news release dated March 2, 2021, but down slightly from the gross margin figures reported for the individual months of November and December 2020.
The Company had cash at January 31, 2021 of $3,017,799 (April 30, 2020 - $5,632,160).
Working capital as at January 31, 2021 is $911,231.
The Company has long-term debt consisting of $819,216 in non-current portion of lease obligations and $92,061 in non-current loans payable.
The net loss and comprehensive loss for the three months ended January 31, 2021 was $626,878 (as compared to January 31, 2020 of $33,144,218). The loss for the three-month quarter ended January 31, 2021 (with comparisons for the quarter ended January 31, 2020) is mainly attributed to the following:
depreciation and amortization expense of $157,600 (2020 - $775,844), consulting fees of $8,500 (2020 - $132,102),; filing fees of $25,592 (2020 - $26,075); development and research expenses of $97,600 (2020 - $830,180); lease interest of $66,151 (2020 - $42,348); office expense of $140,684 (2020 - $156,933); professional fees of $166,328 (2020 - $195,315); management fees of $55,500 (2020 - $57,675), remuneration and benefits of $544,140 (2020 - $640,550); share-based payments of $11,865 (2020 - $241,131) and impairment loss of $Nil (2020 - 29,364,656)
Company Summary and Highlights
Pineapple Express Delivery Inc.
World-Class holds a controlling interest in Pineapple Express Delivery Inc. ("PED"), a company which offers compliant and secure delivery of government regulated products, including medical and recreational cannabis in Ontario, Manitoba and Saskatchewan, and liquor delivery in certain jurisdictions in Saskatchewan.
Since the Company's acquisition of a controlling interest in PED, PED has achieved the following milestones:
A total of 580,732 cannabis and alcohol deliveries for the nine months ended January 31, 2021 were made. The fluctuations in deliveries quarter over quarter are due to the COVID-19 lockdown measures put in place in the Greater Toronto Area with volumes increasing during these lockdowns. Total deliveries per quarters: 209,676 - three months ended January 31, 2021, 181,569 - three months ended October 31, 2020 and 189,487 - three months ended July 31, 2020.
The number of drivers changed from 55 at the beginning of 2020, to approximately 190 by the end of July 31, 2020, 180 by October 31, 2020 and 200 by January 31, 2021. Efficiencies have also been created by routing deliveries through hub expansions and concentrating drivers to tighter geographical areas, leading to less hours used by drivers for the timely delivery of packages.
Offering same day cannabis delivery service in 37 cities (183 postal code regions) and 3-day service in 65 cities (288 postal code regions) in Ontario, PED expanded cannabis delivery services to Ottawa, Barrie, Kingston, London, and the Windsor/Chatham region.
Expanded liquor delivery services to provide same-day and next-day delivery of wine, spirits and beer products from Saskatoon Co-op's Wine-Spirits-Beer retail stores in Saskatoon, Warman and Martensville.
Partnered with Medical Cannabis by Shoppers™ to offer same-day delivery to their medical cannabis patients in cities in and around the Greater Toronto Area (GTA).
Partnered with Spectrum Therapeutics, the medical division of Canopy Growth Corporation to bring same-day delivery to medical cannabis patients in the GTA.
Partnered with CannTrust Inc. to provide deliveries for estoraTM medical cannabis products to CannTrust patients in Ontario, under the name "Trust Delivery - Powered by Pineapple Express".
Several contracts in place with Health Canada license holders for delivery within select provinces in Canada (B2B cannabis delivery services).
Late-stage applicant to Health Canada to obtain a ‘Sale for Medical Purposes' license for its facility located in the GTA. With a population of 6-million people, this sales license gives PED the ability to store inventory for other license holders, allowing PED to leverage its facility in the GTA and offer same day delivery services to the patients of those LPs.
The Company cautions that figures for revenue, gross margin, and number of deliveries generated from the services offered by Pineapple Express Delivery have not been audited beyond April 30, 2020 and any monthly updates are based on calculations prepared by the Company and management of Pineapple Express Delivery. Actual results may differ from those reported in this release once figures have been audited.
Soma Labs
The Company's subsidiary, Soma Labs Scientific Inc. ("Soma"), has focused on production, quality and compliance of systems, technologies, processes and procedures for cannabis and hemp extraction and processing, including the BOSS CO2 Extraction System and the BEAST Ethanol Extraction System. World-Class continues to focus on monetizing its Soma Labs' assets, including the extraction and processing systems, technology and processes to produce cannabis and hemp concentrates and end-products.
Patent Applications and Information
The Company has previously filed, and will continue to file, patent applications directed to its proprietary systems and methods for producing cannabis and hemp extracts. Such systems and methods are believed to be novel and non-obvious, based on the ability of the World-Class Technologies to produce extracts that have substantially greater concentrations of target cannabinoids and possess minimal contaminants. Additional advantages of the World-Class Technologies include the ability to process very large volumes of cannabis and hemp plant material.
The United States Patent and Trademark Office ("USPTO") has awarded the Company the following U.S. Patents:
U.S. Patent No. 10,851,077, issued on December 1, 2020 in relation to the Company's methods for extracting and concentrating cannabinoids and other target compounds from cannabis using ultrasound-enhanced solvent extraction. WCE's patented plant processing technology allows for prompt cannabinoid extraction following harvest, including the root and all other parts of the hemp plant and further utilizes ethanol for extraction, as opposed to the use of toxic hydrocarbon solvents. WCE's patented process additionally uses precisely focused ultrasound to release cannabinoids from the hemp plant that produces CBD yields that are believed to be among the highest in the industry while also minimizing biomass waste and solvent usage.
U.S. Patent No. 10,946,306, issued on March 16, 2021 in relation to the Company's methods for the systematic extraction and concentration of cannabinoids and other target compounds via solvent extraction from large scale harvests of cannabis and hemp crops. World-Class' patent process minimizes energy consumption, conserves the volume of solvent utilized in the extraction process, and maximizes the quantity of cannabinoids sought to be extracted on a large-scale, commercial basis, than other known cannabinoid extraction techniques.
These patents continue to supplement World-Class' goal to achieve the most sustainable, efficient, and economical method of large-scale commercial production of cannabis plant material.
Update regarding Cobra Ventures & HydRx Farms Debenture Investment
During the period ended January 31, 2021, World-Class provided a $2.5M loan to Cobra Ventures Inc. ("Cobra") with respect to a debenture purchase of HydRx Farms Ltd. operating as Scientus Pharma("HydRx"). World-Class subsequently sold its 50% interest in Cobra to the remaining shareholder of Cobra, the sale of which included the receipt of all funds ($2.5 million) previously advanced by World-Class to Cobra. The World-Class loan was paid out in full, and World-Class has no further interest in Cobra and no ongoing role or involvement with HydRx or the HydRx debenture.
About World-Class Extractions Inc.
World-Class is an innovation-driven company with a principle focus on the rapidly evolving cannabis and hemp industries. World-Class offers compliant and secure delivery of government regulated products through its subsidiary Pineapple Express Delivery Inc., including medical and recreational cannabis in Ontario, Manitoba and Saskatchewan, and liquor delivery in certain jurisdictions in Saskatchewan. World-Class continues to investigate opportunities to deploy and manage custom-built extraction centres utilizing its custom systems, technology, and processes to efficiently produce high-quality cannabis and hemp concentrates and end-products.
Contact
World-Class Investor Relations
1-437-266-1968
ir@worldclassextractions.com
https://worldclassextractions.com
https://seekingalpha.com/pr/18245831-world-class-extractions-reports-operating-and-financial-results-for-nine-month-period-ended
NYTimes: New York Reaches a Deal to Legalize Recreational Marijuana
New York Reaches a Deal to Legalize Recreational Marijuana ... Andrew M. Cuomo to allow the recreational use of cannabis for adults 21 and ... could be consumed, according to details obtained by The New York Times.
https://www.nytimes.com/2021/03/25/nyregion/ny-legalize-marijuana.html?action=click&module=Top%20Stories&pgtype=Homepage
REPEAT ORDERS! "The same orders will be distributed to pharmaceutical wholesalers and distributors as well as retail chain stores such as Publix and Wal-Mart by our customer. We anticipate the repeat orders of the same. $SHMN (2/2)"
The same orders will be distributed to pharmaceutical wholesalers and distributors as well as retail chain stores such as Publix and Wal-Mart by our customer. We anticipate the repeat orders of the same. $SHMN (2/2)
— SOHM, Inc. (@sohminc) February 22, 2021
Plus more products, and don't forget Walmart and Publix!
I believe more, lots of investors holding for 5, 10, 20 cents share price.. I believe sometime this year possible! when you look at some OTC stocks that are trading at dollarland without 1 dollar revenue and profit and plus billions of shares..
Plus NO R/S & Float 1.2 Billion
Wow that's amazing! Rare to find in the OTC companies that are debt free with no convertible notes or promissory notes and have revenues with positive net profit. Go $SHMN
True have a look at TGG*I
"we are happy with our ongoing efforts and actions on strengthening our revenues and operation $SHMN"
The company once again reiterate its earlier announcement that there is no plan of Reverse Split currently, we are happy with our ongoing efforts and actions on strengthening our revenues and operation $SHMN https://t.co/a2OcOBpjXt
— SOHM, Inc. (@sohminc) March 24, 2021
NO R/S!: "The company once again reiterate its earlier announcement that there is no plan of Reverse Split currently, we are happy with our ongoing efforts and actions on strengthening our revenues and operation $SHMN"
The company once again reiterate its earlier announcement that there is no plan of Reverse Split currently, we are happy with our ongoing efforts and actions on strengthening our revenues and operation $SHMN https://t.co/a2OcOBpjXt
— SOHM, Inc. (@sohminc) March 24, 2021
Definitely agree!
She is now ready for its march to many pennies...
No RS per Company tweet
Growing Revenues per filings
Market Cap only 13m
Float only 1.2b
And about to go current
Walmart and Publix Revenue at Q1 2021..
The same orders will be distributed to pharmaceutical wholesalers and distributors as well as retail chain stores such as Publix and Wal-Mart by our customer. We anticipate the repeat orders of the same. $SHMN (2/2)
The same orders will be distributed to pharmaceutical wholesalers and distributors as well as retail chain stores such as Publix and Wal-Mart by our customer. We anticipate the repeat orders of the same. $SHMN (2/2)
— SOHM, Inc. (@sohminc) February 22, 2021